Symptomatic causes of restless legs syndrome

被引:0
作者
Carrillo, F. [1 ]
Mir, P. [1 ]
机构
[1] Hosp Univ Virgen del Rocio, Serv Neurol, Unidad Trastornos Movimiento, Seville 41013, Spain
来源
NEUROLOGIA | 2009年 / 24卷 / 10期
关键词
Restless legs syndrome; Symptomatic; Iron deficiency; Parkinson's disease; Neuropathy; Myelopathy; LIMB MOVEMENT-DISORDER; SUBTHALAMIC STIMULATION; SYNDROME RLS; TRANSFERRIN; DISEASE; SLEEP; BRAIN; IRON;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Restless legs syndrome (RLS) is characterized by discomfort and paresthesias in the legs with urge to move the legs, worsening of the symptoms with the rest or inactivity, present or exacerbation in the evening or night and partial or total relief with movement. The diagnosis is primarily clinical. RLS is idiopathic, with family history in 40-60% of the cases, or symptomatic associated conditions such as iron deficiency, uremia, pregnancy, Parkinson's disease, neuropathy or myelopathy. Although the pathophysiology of RLS remains unknown, it has been implicated a central dopaminergic dysfunction. In the last years it has increased the interest and has been published several papers about RLS, that intake significant contributions to the current understanding of the syndrome. The aim of this paper is to review the cur-rent advances in the field of RLS, with special emphasis on symptomatic causes of the syndrome, from both epidemiological and pathophysiological points of view.
引用
收藏
页码:841 / 844
页数:4
相关论文
共 42 条
[1]   Restless legs syndrome - A review of clinical and pathophysiologic features [J].
Allen, RP ;
Earley, CJ .
JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2001, 18 (02) :128-147
[2]   Augmentation of the restless legs syndrome with carbidopa/levodopa [J].
Allen, RP ;
Earley, CJ .
SLEEP, 1996, 19 (03) :205-213
[3]   Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS [J].
Appiah-Kubi, L. S. ;
Pal, S. ;
Chaudhuri, K. Ray .
SLEEP MEDICINE, 2002, 3 :S51-S55
[4]  
ARILLO VMC, 2006, REV ESP TRAST MOV, V1, P12
[5]   Sex and the risk of restless legs syndrome in the general population [J].
Berger, K ;
Luedemann, J ;
Trenkwalder, C ;
Ulrich, J ;
Kessler, C .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) :196-202
[6]  
CHAUDHURI KR, 2003, PRAC NEUROL, V3, P204
[7]   Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome [J].
Connor, JR ;
Wang, XS ;
Patton, SM ;
Menzies, SL ;
Troncoso, JC ;
Earley, CJ ;
Allen, RP .
NEUROLOGY, 2004, 62 (09) :1563-1567
[8]  
DEGRANDIS E, 2008, PARKINSONISM RELAT D
[9]   Restless legs syndrome in fabry disease:: Clinical feature associated to neuropathic pain is overlooked [J].
Domínguez, R. O. ;
Michref, A. ;
Tanus, E. ;
Amartino, H. .
REVISTA DE NEUROLOGIA, 2007, 45 (08) :474-478
[10]   Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome [J].
Earley, CJ ;
Connor, JR ;
Beard, JL ;
Malecki, EA ;
Epstein, DK ;
Allen, RP .
NEUROLOGY, 2000, 54 (08) :1698-1700